GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
0 hedge funds and large institutions have $0 invested in VanEck Vectors Generic Drugs ETF in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$257K |
| 2 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$142K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$257K | -11,614 | Closed |
|
|
APA
2
American Portfolios Advisors
Holbrook,
New York
| – | -$142K | -6,419 | Closed |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$15K | -660 | Closed |
|